Cutting Edge: Cytosolic Receptor AIM2 Is Induced by Peroxisome Proliferator-activated Receptor γ following Mycobacterium tuberculosis Infection of Human Macrophages but Does Not Contribute to IL-1β Release.
Eusondia ArnettJade WolffChrissy M Leopold WagerJan SimperJeanine L BadrakCarlos O OntiverosBin NiLarry S SchlesingerPublished in: Journal of immunology (Baltimore, Md. : 1950) (2024)
AIM2 (absent in melanoma 2), an inflammasome component, mediates IL-1β release in murine macrophages and cell lines. AIM2 and IL-1β contribute to murine control of Mycobacterium tuberculosis (M.tb) infection, but AIM2's impact in human macrophages, the primary niche for M.tb, remains unclear. We show that M.tb, Mycobacterium bovis bacillus Calmette-Guérin (BCG), and M. smegmatis induce AIM2 expression in primary human macrophages. M.tb-induced AIM2 expression is peroxisome proliferator-activated receptor γ (PPARγ)-dependent and M.tb ESX-1-independent, whereas BCG- and M. smegmatis-induced AIM2 expression is PPARγ-independent. PPARγ and NLRP3, but not AIM2, are important for IL-1β release in response to M.tb, and NLRP3 colocalizes with M.tb. This is in contrast to the role for AIM2 in inflammasome activation in mice and peritoneal macrophages. Altogether, we show that mycobacteria induce AIM2 expression in primary human macrophages, but AIM2 does not contribute to IL-1β release during M.tb infection, providing further evidence that AIM2 expression and function are regulated in a cell- and/or species-specific manner.
Keyphrases
- mycobacterium tuberculosis
- poor prognosis
- endothelial cells
- binding protein
- high glucose
- induced pluripotent stem cells
- magnetic resonance
- stem cells
- insulin resistance
- type diabetes
- adipose tissue
- computed tomography
- oxidative stress
- pluripotent stem cells
- bone marrow
- skeletal muscle
- mesenchymal stem cells
- single cell
- cell therapy